Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells

Liu,Hui; Zou,Manman; Li,Pei; Wang,Haifeng; Lin,Xijun; Ye,Jin

doi:10.3892/mmr.2019.10064

Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells

Authors:
- Hui Liu
- Manman Zou
- Pei Li
- Haifeng Wang
- Xijun Lin
- Jin Ye
View Affiliations

Affiliations: Division of Pulmonary and Critical Care, Department of Internal Medicine, The Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 501630, P.R. China, Department of Otolaryngology‑Head and Neck Surgery, The Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 501630, P.R. China
Published online on: March 20, 2019 https://doi.org/10.3892/mmr.2019.10064
Pages: 4081-4090
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The dendritic cell (DC)‑regulatory T (Treg) system serves a leading role in the immunosuppression of the tumor microenvironment, which is not conducive to radiotherapy and chemotherapy treatment for lung cancer. The present study aimed to investigate the effect of oxymatrine (OMT) on the DC‑Treg system in the tumor microenvironment in vitro and to examine its mechanism. The expressions of CD83 antigen, T‑lymphocyte activation antigen CD86, CD11 antigen‑like family member C and major histocompatibility complex II in DCs were increased upon treatment with 1 mg/ml OMT, as detected by flow cytometry. Following pretreatment with OMT, the DCs mediated the forkhead box protein P3 overexpression in primitive cluster of differentiation 4+ T cells at the protein and mRNA expression levels. The expression levels of anti‑inflammatory factors, including interleukin (IL)‑10, tumor growth factor‑β, IL‑35, and pro‑inflammatory cytokines, including interferon‑γ, IL‑12 and IL‑2, in the co‑culture supernatant were increased as measured by ELISA. When DCs and DC‑Tregs were co‑cultured with cisplatin‑resistant A549 cells, the proportion of apoptosis in the co‑culture groups was increased under treatment with cisplatin, which was detected by Annexin V/propidium Iodide staining and western blotting. The present results suggested that OMT may promote the maturation of DCs, mediate the differentiation of T cells into Treg cells, and reverse the resistance of tumor cells to cisplatin in vitro. It was suggested that OMT is an important adjunct to chemotherapy through the regulation of antitumor responses.

View Figures

View References

1	Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and Su C: Antitumor activities of matrine and oxymatrine: Literature review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
2	Parvez MK, Arbab AH, Al-Dosari MS and Al-Rehaily AJ: Antiviral natural products against chronic hepatitis B: Recent developments. Curr Pharm Des. 22:286–293. 2016. View Article : Google Scholar : PubMed/NCBI
3	Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ and Tao HM: Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
4	Zhao B, Li B, Bai S, Shen L, Ren R, Jonas JB, Xu X, Lu Q and Liu Q: Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 250:897–905. 2012. View Article : Google Scholar : PubMed/NCBI
5	Xing Y, Yan F, Liu Y, Liu Y and Zhao Y: Matrine inhibits 3T3-L1 preadipocyte differentiation associated with suppression of ERK1/2 phosphorylation. Biochem Biophys Res Commun. 396:691–695. 2010. View Article : Google Scholar : PubMed/NCBI
6	Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, Wu J, Yu K and Han Y: Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS One. 7:e468532012. View Article : Google Scholar : PubMed/NCBI
7	Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H, Lu D, Bu H, Zhang R and Lin S: Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Oncol Rep. 30:589–595. 2013. View Article : Google Scholar : PubMed/NCBI
8	Yu H, Zhang H, Li D, Zhang X, Xue H and Zhao S: Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res. 13:242–250. 2011. View Article : Google Scholar : PubMed/NCBI
9	Sun Q, Ma W, Gao Y, Zheng W, Zhang B and Peng Y: Meta-analysis: Therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med. 9:178–188. 2012. View Article : Google Scholar : PubMed/NCBI
10	Villadangos JA, Schnorrer P and Wilson NS: Control of MHC class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol Rev. 207:191–205. 2005. View Article : Google Scholar : PubMed/NCBI
11	Merad M, Sathe P, Helft J, Miller J and Mortha A: The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 31:563–604. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1109–1118. 1994. View Article : Google Scholar : PubMed/NCBI
13	Ghiringhelli F and Apetoh L: The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy. Expert Rev Clin Immunol. 10:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
14	Dong Y, Xi H, Yu Y, Wang Q, Jiang K and Li L: Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol. 17:1299–1306. 2002. View Article : Google Scholar : PubMed/NCBI
15	Zhou Y, Wang HL, Zhao WC, Chen Y and Deng HZ: Total alkaloids of Sophora alopecuroides increases the expression of CD₄⁺ CD25⁺ Tregs and IL-10 in rats with experimental colitis. Am J Chin Med. 38:265–277. 2010. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Stein J, Steven S, Bros M, Sudowe S, Hausding M, Oelze M, Münzel T, Grabbe S, Reske-Kunz A and Daiber A: Role of protein kinase C and Nox2-derived reactive oxygen species formation in the activation and maturation of dendritic cells by phorbol ester and lipopolysaccharide. Oxid Med Cell Longev. 2017:41572132017. View Article : Google Scholar : PubMed/NCBI
18	Li S, Zhang Y, Liu Q, Zhao Q, Xu L, Huang S, Huang S and Wei X: Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest. Oncol Lett. 13:4453–4458. 2017. View Article : Google Scholar : PubMed/NCBI
19	Lin B, Li D and Zhang L: Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells. Pharmazie. 71:154–157. 2016.PubMed/NCBI
20	Sarhan D, Palma M, Mao Y, Adamson L, Kiessling R, Mellstedt H, Österborg A and Lundqvist A: Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β. Eur J Immunol. 45:1783–1793. 2015. View Article : Google Scholar : PubMed/NCBI
21	Dudek AM, Martin S, Garg AD and Agostinis P: Immature, semi-mature, and fully mature dendritic cells: Toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 4:4382013. View Article : Google Scholar : PubMed/NCBI
22	Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C and Blay JY: Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Rrole of interleukin-6 and macrophage colony-stimulating factor. Blood. 92:4778–4791. 1998.PubMed/NCBI
23	Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA and Banchereau J: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 190:1417–1426. 1999. View Article : Google Scholar : PubMed/NCBI
24	Sittig S, de Vries I and Schreibelt G: Primary human blood dendritic cells for cancer immunotherapy-tailoring the immune response by dendritic cell maturation. Biomedicines. 3:282–303. 2015. View Article : Google Scholar : PubMed/NCBI
25	Joffre O, Nolte MA, Spörri R and Reis e Sousa C: Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev. 227:234–247. 2009. View Article : Google Scholar : PubMed/NCBI
26	Ma A, Yang Y, Wang Q, Yin W, Jing W and Zhang Y: Anti-inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells. Mol Med Rep. 15:3615–3622. 2017. View Article : Google Scholar : PubMed/NCBI
27	Mao Y, Poschke I and Kiessling R: Tumour-induced immune suppression: Role of inflammatory mediators released by myelomonocytic cells. J Intern Med. 276:154–170. 2014. View Article : Google Scholar : PubMed/NCBI
28	Noy R and Pollard JW: Tumor-associated macrophages: From mechanisms to therapy. Immunity. 41:492014. View Article : Google Scholar : PubMed/NCBI
29	Jandus C, Bioley G, Speiser D and Romero P: Selective accumulation of differentiated FOXP3(+) CD4 (+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood. Cancer Immunol Immunother. 57:1795–1805. 2008. View Article : Google Scholar : PubMed/NCBI
30	Yeong J, Thike AA, Lim JC, Lee B, Li H, Wong SC, Hue SS, Tan PH and Iqbal J: Higher densities of Foxp3⁺ regulatory T cells are associated with better prognosis in triple-negative breast cancer. Breast Cancer Res Treat. 163:21–35. 2017. View Article : Google Scholar : PubMed/NCBI
31	Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Bajoriunas V, Lavinskiene S and Sakalauskas R: The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancer. J Inflamm (Lond). 12:632015. View Article : Google Scholar : PubMed/NCBI
32	West NR, Kost SE, Martin SD, Milne K, Deleeuw RJ, Nelson BH and Watson PH: Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. Br J Cancer. 108:155–162. 2013. View Article : Google Scholar : PubMed/NCBI
33	Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, et al: Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck. 32:946–958. 2010.PubMed/NCBI
34	Musolino C, Allegra A, Pioggia G and Gangemi S: Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer. Oncol Rep. 37:671–683. 2017. View Article : Google Scholar : PubMed/NCBI
35	Gao F, Liang B, Reddy S, Farias-Eisner R and Su X: Role of inflammation-associated microenvironment in tumorigenesis and metastasis. Curr Cancer Drug Targets. 14:30–45. 2014. View Article : Google Scholar : PubMed/NCBI
36	Beatty GL: Overcoming therapeutic resistance by targeting cancer inflammation. Am Soc Clin Oncol Educ Book. 35:e168–e173. 2016. View Article : Google Scholar : PubMed/NCBI
37	Xu G, Yao L, Rao S, Gong Z, Zhang S and Yu S: Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. J Ethnopharmacol. 98:177–183. 2005. View Article : Google Scholar : PubMed/NCBI
38	Chen X, Sun R, Hu J, Mo Z, Yang Z, Liao D and Zhong N: Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture. Basic Clin Pharmacol Toxicol. 103:278–286. 2008. View Article : Google Scholar : PubMed/NCBI
39	Hu ST, Tang Y, Shen YF, Ao HH, Bai J, Wang YL and Yang YJ: Protective effect of oxymatrine on chronic rat heart failure. J Physiol Sci. 61:363–372. 2011. View Article : Google Scholar : PubMed/NCBI
40	Jiang G, Liu X, Wang M, Chen H, Chen Z and Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras. 30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
41	Ning Y and Xin W: Effect on Toll-like receptor 7 signaling pathway in PBMCs of chronic hepatitis B patients by oxymatrine in vitro. Chin Arch Trad Chin Med. 36:1196–1199. 2018.
42	Zhang J and Tang A: Reversal effect of matrine on drug resistance of human nasopharyngeal carcinoma cell line. Zhong Yao Cai. 35:1989–1994. 2012.(In Chinese). PubMed/NCBI
43	Wang HQ, Jin JJ and Wang J: Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling. Oncol Rep. 33:2561–2566. 2015. View Article : Google Scholar : PubMed/NCBI
44	Luo SX, Deng WY, Wang XF, Lü HF, Han LL, Chen BB, Chen XB and Li N: Molecular mechanism of indirubin-3′-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line. Chin Med J (Eng). 126:925–929. 2013.
45	Chai S, To KK and Lin G: Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chin Med. 5:262010. View Article : Google Scholar : PubMed/NCBI
46	Wang B, Han Q and Zhu Y: Oxymatrine inhibited cell proliferation by inducing apoptosis in human lung cancer A549 cells. Biomed Mater Eng. 26 (Suppl 1):S165–S172. 2015.PubMed/NCBI
47	Truxova I, Hensler M, Skapa P, Halaska MJ, Laco J, Ryska A, Spisek R and Fucikova J: Rationale for the combination of dendritic cell-based vaccination approaches with chemotherapy agents. Int Rev Cell Mol Biol. 330:115–156. 2017. View Article : Google Scholar : PubMed/NCBI
48	Di Blasio S, Wortel IM, van Bladel DA, de Vries LE, Duiveman-de Boer T, Worah K, de Haas N, Buschow SI, de Vries IJ, Figdor CG and Hato SV: Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 5:e11927392016. View Article : Google Scholar : PubMed/NCBI
49	Palucka K and Banchereau J: Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 12:265–277. 2012. View Article : Google Scholar : PubMed/NCBI